News and Updates
Jayakrishna Ambati, M.D., has been appointed Vice President, Advanced Ocular Design and Director
Dr. Jayakrishna Ambati is Professor and Vice Chair of Ophthalmology and Visual Sciences, and Dr. E. Vernon & Eloise C. Smith Endowed Chair at the University of Kentucky. Dr. Ambati is a retinal surgeo
Raj Patil, Ph.D., joins iVeena as Vice President, Advanced Ocular Delivery Systems
Dr. Patil brings more than 20 years of academic and pharmaceutical experience in Ophthalmology. Prior to joining iVeena, Dr. Patil worked at Alcon from 2004 to 2011 and at Novartis Institute of Biomed
Sarah Molokhia, R.Ph., Ph.D., appointed iVeena Director, Research and Development
Sarah Molokhia has over 12 years in ocular drug delivery experience. Most recently, Sarah was working as a Research Consultant with Aciont, Inc. an ocular drug delivery company in clinical trials. Aft
iVeena founder, Dr. Bala Ambati, voted #1 ophthalmologist in the world under 40 years of age
Dr. Ambati was cited by The Ophthalmologist Magazine as the number one ophthalmologist in the world under 40 years of age for his contributions to ophthalmic research and humanitarian activities. Re
iVeena completes Pre-IND meeting with FDA for BDI-1 and BDI-2.
iVeena completed a pre-IND call with the FDA delineating the clinical development pathway, required elements for the GLP study, and endpoints of a Phase 1/2a trial. The BDI would be treated as a drug
Page 8 of 9